Browsing by Subject "Combination size"
Now showing items 1-2 of 2
-
Impact of treatment size and molecular types of breast cancer on response rate and progression-free survival
(Brac University, 2022-08)According to the American Cancer Society's projections, there will be 339,250 cases of breast cancer and 43,250 women will pass away due to this cancer in the year 2022. Moreover, breast cancer is responsible for 15% ... -
Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
(Brac University, 2023-10)Lung cancer is a prominent cause of death annually. It is the most common cancer worldwide and the leading cause of cancer deaths in men and women. In this research, we focused mostly on non-small cell lung cancer (NSCLC) ...
